TiO2 Chromatography for Sialylated Peptide Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and analyzing sialylated and phosphorylated peptides are cumbersome, expensive, or not suited for mass spectrometry, and fail to efficiently identify biomarkers associated with changes in protein sialylation status.
Innovation Solution
A method using titanium dioxide or zirconium dioxide chromatographic stationary phase with a loading buffer containing substituted aromatic carboxylic acids or short chain hydroxylated carboxylic acids, allowing for the isolation and analysis of sialylated and phosphorylated peptides by mass spectrometry, enabling the identification of biomarkers through efficient separation and characterization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lectin affinity chromatography or anion exchange methods are used for isolation of sialylated proteins, then purification effectiveness is improved, but procedure complexity and cost increase
Solution Approach 1:
The invention changes the chemical parameters of the loading buffer by incorporating substituted aromatic carboxylic acids (such as dihydroxy benzoic acid or phthalic acid) at specific concentrations (6.5-50 mM) to enhance the binding selectivity of titanium dioxide stationary phase for sialylated peptides, achieving effective purification with a simpler, more cost-effective method
Solution Approach 2:
The invention replaces expensive lectin affinity chromatography materials and complex anion exchange procedures with a disposable titanium dioxide stationary phase system that uses inexpensive aromatic carboxylic acid additives, reducing both material cost and procedural complexity while maintaining high purification effectiveness
2Reliability
If conventional isolation methods are used, then separation capability is improved, but compatibility with mass spectrometry analysis deteriorates
Solution Approach 1:
The invention optimizes the loading buffer composition with specific concentrations of aromatic carboxylic acids and organic phase (20-80%) to achieve separation of sialylated peptides while maintaining buffer conditions that are compatible with subsequent mass spectrometry analysis, eliminating the need for additional buffer exchange steps
Solution Approach 2:
The titanium dioxide stationary phase system serves multiple functions: it provides effective separation of sialylated peptides while simultaneously producing eluates that are directly compatible with mass spectrometry analysis, making the method universally applicable for both purification and analytical purposes
3Reliability
If existing purification techniques are applied, then isolation effectiveness is improved, but cost and procedural time increase
Solution Approach 1:
The invention modifies the loading buffer by adding substituted aromatic carboxylic acids at optimized concentrations to enhance the binding affinity and selectivity of titanium dioxide for sialylated peptides, achieving effective isolation in a single step without requiring multiple purification stages, thereby reducing both time and cost
Solution Approach 2:
The invention segments the complex purification process into a simplified two-step procedure: (1) loading the sample in acidic buffer containing aromatic carboxylic acid onto titanium dioxide stationary phase, and (2) eluting with alkaline buffer, achieving effective isolation of sialylated peptides with minimal procedural steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a simple, cost-effective means for isolating and analyzing sialylated and phosphorylated peptides, facilitating the identification of biomarkers associated with changes in protein sialylation status, enhancing diagnostic and prognostic capabilities for various conditions.
Implementation Method 1
A sample is loaded onto titanium dioxide (TiO2) or zirconium dioxide (ZrO2) stationary phase under acidic conditions
Implementation Method 2
Sialic acid containing proteins can then be eluted from loaded stationary phase material by exposure to an alkaline solution having pH of 9.0 or greater
Data Source
AI summary
Changes in sialylation of cell surface or plasma proteins are often associated with various cancers and other disease conditions. Provided are methods of detecting biomarkers of conditions associated with a change of sialylation status. Sialylated peptides are first isolated from biological and other samples by loading onto titanium dioxide (TiO2) or zirconium dioxide (ZrO2) stationary phase under acidic conditions in a solution comprising at least 20% organic phase and at least about 6.5 mM of substituted aromatic carboxylic acid, or, alternatively, at least about 11 mM short chain, non-aromatic, hydroxylated carboxylic acid. Sialic acid containing proteins can then be eluted from loaded stationary phase material by exposure to an alkaline solution having pH of 9.0 or greater, preferably at least 10.5. Sialylated peptides isolated by the methods provided can then be analysed by mass spectrometry to identify patterns of sialylation across a sialiome (the entire complement of sialic acid containing peptides in a biological sample) and/or to identify proteins in a sample that are sialylated or that show changes in sialylation status between two or more different samples. In preferred embodiments, sialylated peptides from control and patient samples can be differentially isotopically labelled and compared in a single mass sprectrometry experiment. Also provided are specific biomarkers of bladder cancer. The methods for isolating and analysing sialylated proteins can also by applied to phosphorylated proteins.